委员会意见第713号摘要:胎儿成熟度的产前皮质类固醇治疗
该委员会意见指出,单疗程皮质类固醇推荐用于24 0/7周至33 6/7周、7天内有早产风险孕妇,包括胎膜早破和多胎妊娠;23 0/7周起可基于家庭复苏决策考虑;34 0/7周至36 6/7周未接受过皮质类固醇且7天内有早产风险者可考虑倍他米松;并给出重复疗程和补救疗程的考虑条件。
要点
- 单疗程皮质类固醇推荐用于24 0/7至33 6/7周、7天内有早产风险孕妇,包括胎膜早破和多胎妊娠。
- 23 0/7周起可基于家庭复苏决策考虑;34 0/7至36 6/7周未用过皮质类固醇者可考虑倍他米松。
- 既往皮质类固醇给药超过14天、不足34 0/7周且7天内有早产风险者可考虑单次重复疗程。
核心结论
- 产前皮质类固醇是改善新生儿结局最重要的产前治疗之一,推荐单疗程用于24 0/7周至33 6/7周、7天内有早产风险孕妇,包括胎膜早破和多胎妊娠。
- 23 0/7周起可基于家庭复苏决策考虑使用,不论胎膜破裂状态和胎儿数目;34 0/7至36 6/7周未接受过产前皮质类固醇且7天内有早产风险者可考虑倍他米松。
- 不足34 0/7周、7天内有早产风险且既往产前皮质类固醇给药超过14天者可考虑单次重复疗程;如临床情况需要,补救疗程可最早于前次给药后7天给予。
研究设计与样本
- 美国妇产科医师学会(Obstet Gynecol)发布的委员会意见第713号摘要。
主要发现
- 单疗程皮质类固醇推荐用于24 0/7周至33 6/7周、7天内有早产风险孕妇,包括胎膜早破和多胎妊娠。
- 23 0/7周起可基于家庭复苏决策考虑使用,不论胎膜破裂状态和胎儿数目。
- 34 0/7周至36 6/7周、7天内有早产风险且未接受过产前皮质类固醇者可考虑倍他米松。
- 不足34 0/7周、7天内有早产风险且既往产前皮质类固醇给药超过14天者可考虑单次重复疗程。
- 如临床情况需要,补救疗程可最早于前次给药后7天给予。
关键数值与推荐
- 单疗程皮质类固醇推荐用于24 0/7周至33 6/7周、7天内有早产风险孕妇,包括胎膜早破和多胎妊娠。
- 23 0/7周起可基于家庭复苏决策考虑使用,不论胎膜破裂状态和胎儿数目。
- 34 0/7周至36 6/7周、7天内有早产风险且未接受过产前皮质类固醇者可考虑倍他米松。
- 不足34 0/7周、7天内有早产风险且既往产前皮质类固醇给药超过14天者可考虑单次重复疗程。
- 如临床情况需要,补救疗程可最早于前次给药后7天给予。
临床怎么用
- 对24 0/7周至33 6/7周、7天内有早产风险孕妇(包括胎膜早破和多胎妊娠)给予单疗程皮质类固醇。
- 对23 0/7周起、7天内有早产风险孕妇,基于家庭复苏决策考虑使用,不论胎膜破裂状态和胎儿数目。
- 对34 0/7周至36 6/7周、7天内有早产风险且未接受过产前皮质类固醇者考虑倍他米松。
- 对不足34 0/7周、7天内有早产风险且既往产前皮质类固醇给药超过14天者考虑单次重复疗程;如临床情况需要,补救疗程可最早于前次给药后7天给予。
- 应支持对宫内皮质类固醇暴露后长期结局的持续监测,并鼓励采用质量改进策略优化适当且及时的产前皮质类固醇给药。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Corticosteroid administration before anticipated preterm birth is one of the most important antenatal therapies available to improve newborn outcomes. A single course of corticosteroids is recommended for pregnant women between 24 0/7 weeks and 33 6/7 weeks of gestation who are at risk of preterm delivery within 7 days, including for those with ruptured membranes and multiple gestations. It also may be considered for pregnant women starting at 23 0/7 weeks of gestation who are at risk of preterm delivery within 7 days, based on a family's decision regarding resuscitation, irrespective of membrane rupture status and regardless of fetal number. Administration of betamethasone may be considered in pregnant women between 34 0/7 weeks and 36 6/7 weeks of gestation who are at risk of preterm birth within 7 days, and who have not received a previous course of antenatal corticosteroids. A single repeat course of antenatal corticosteroids should be considered in women who are less than 34 0/7 weeks of gestation who are at risk of preterm delivery within 7 days, and whose prior course of antenatal corticosteroids was administered more than 14 days previously. Rescue course corticosteroids could be provided as early as 7 days from the prior dose, if indicated by the clinical scenario. Continued surveillance of long-term outcomes after in utero corticosteroid exposure should be supported. Quality improvement strategies to optimize appropriate and timely antenatal corticosteroid administration are encouraged.
引用
- Committee Opinion No. 713 Summary: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017. PMID: 28742672. doi:10.1097/AOG.0000000000002231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。